Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer

We present a rare case of tuberculous spondylitis following intravesical Bacillus Calmette-Guerin (BCG) therapy for bladder cancer. An 82-year-old man presented with low back pain. Past medical history revealed bladder cancer diagnosed and treated 16 months previously by intravesical BCG. Magnetic r...

Full description

Saved in:
Bibliographic Details
Main Authors: Masashi Miyazaki, Toyomi Yoshiiwa, Toshinobu Ishihara, Masanori Kawano, Hiroshi Tsumura
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Orthopedics
Online Access:http://dx.doi.org/10.1155/2016/6741284
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545772476825600
author Masashi Miyazaki
Toyomi Yoshiiwa
Toshinobu Ishihara
Masanori Kawano
Hiroshi Tsumura
author_facet Masashi Miyazaki
Toyomi Yoshiiwa
Toshinobu Ishihara
Masanori Kawano
Hiroshi Tsumura
author_sort Masashi Miyazaki
collection DOAJ
description We present a rare case of tuberculous spondylitis following intravesical Bacillus Calmette-Guerin (BCG) therapy for bladder cancer. An 82-year-old man presented with low back pain. Past medical history revealed bladder cancer diagnosed and treated 16 months previously by intravesical BCG. Magnetic resonance imaging of the thoracic spine showed destruction of the T5 and T6 vertebrae and an epidural soft tissue mass with anterior dural sac compression. Due to the progression of vertebral destruction, posterior spinal segmental fusion was performed. Mycobacterium bovis (M. bovis) was identified using multiplex polymerase chain reaction of surgical tissue specimens. The patient was started on an antituberculosis treatment regimen including isoniazid, rifampicin, and ethambutol. After surgery, his back pain resolved completely. At the latest examination, the patient was pain-free with no functional limitations or recurrent infection in clinical or imaging findings. Patients undergoing BCG therapy should be monitored for possible hematogenous spread of mycobacteria to the spine for months or even years after treatment.
format Article
id doaj-art-32682fd325b542caaf5f4aa783604aaa
institution Kabale University
issn 2090-6749
2090-6757
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Orthopedics
spelling doaj-art-32682fd325b542caaf5f4aa783604aaa2025-02-03T07:24:44ZengWileyCase Reports in Orthopedics2090-67492090-67572016-01-01201610.1155/2016/67412846741284Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder CancerMasashi Miyazaki0Toyomi Yoshiiwa1Toshinobu Ishihara2Masanori Kawano3Hiroshi Tsumura4Department of Orthopaedic Surgery, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, JapanDepartment of Orthopaedic Surgery, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, JapanDepartment of Orthopaedic Surgery, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, JapanDepartment of Orthopaedic Surgery, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, JapanDepartment of Orthopaedic Surgery, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, JapanWe present a rare case of tuberculous spondylitis following intravesical Bacillus Calmette-Guerin (BCG) therapy for bladder cancer. An 82-year-old man presented with low back pain. Past medical history revealed bladder cancer diagnosed and treated 16 months previously by intravesical BCG. Magnetic resonance imaging of the thoracic spine showed destruction of the T5 and T6 vertebrae and an epidural soft tissue mass with anterior dural sac compression. Due to the progression of vertebral destruction, posterior spinal segmental fusion was performed. Mycobacterium bovis (M. bovis) was identified using multiplex polymerase chain reaction of surgical tissue specimens. The patient was started on an antituberculosis treatment regimen including isoniazid, rifampicin, and ethambutol. After surgery, his back pain resolved completely. At the latest examination, the patient was pain-free with no functional limitations or recurrent infection in clinical or imaging findings. Patients undergoing BCG therapy should be monitored for possible hematogenous spread of mycobacteria to the spine for months or even years after treatment.http://dx.doi.org/10.1155/2016/6741284
spellingShingle Masashi Miyazaki
Toyomi Yoshiiwa
Toshinobu Ishihara
Masanori Kawano
Hiroshi Tsumura
Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
Case Reports in Orthopedics
title Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
title_full Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
title_fullStr Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
title_full_unstemmed Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
title_short Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
title_sort tuberculous spondylitis following intravesical bacillus calmette guerin for bladder cancer
url http://dx.doi.org/10.1155/2016/6741284
work_keys_str_mv AT masashimiyazaki tuberculousspondylitisfollowingintravesicalbacilluscalmetteguerinforbladdercancer
AT toyomiyoshiiwa tuberculousspondylitisfollowingintravesicalbacilluscalmetteguerinforbladdercancer
AT toshinobuishihara tuberculousspondylitisfollowingintravesicalbacilluscalmetteguerinforbladdercancer
AT masanorikawano tuberculousspondylitisfollowingintravesicalbacilluscalmetteguerinforbladdercancer
AT hiroshitsumura tuberculousspondylitisfollowingintravesicalbacilluscalmetteguerinforbladdercancer